Every debate, every decision, every treatment option in oncology begins with research. This #WorldCancerResearchDay, we honor the ongoing work that fuels innovation and improves outcomes for patients everywhere. #CancerResearch #Oncology #MedicalEducation #GreatDebates

Starting TODAY! Join @greatdebates.bsky.social and Yelena Janjigian, Chief of the MSK Gastrointestinal Oncology Service, to learn about the latest treatments for #gastriccancer and #colorectalcancer. @mskcancercenter.bsky.social #crcsm #GIcancer See the full agenda 📖: bit.ly/48g13pf

Faculty from Sylvester Cancer Center will join us at Great Debates in Solid Tumors this September. Drs. Lopes, Merchant, Paluvoi, and @latinamd.bsky.social bring the insight. Miami brings the view. Sept 13–14 | gdsolidtumors.com #GDST25 #Oncology #MedicalEducation

You're making treatment decisions every day. But who’s helping you weigh the latest data, options, and gray areas in hematologic care? Join a room full of engaged clinicians and expert voices who don’t just present the data—they challenge it. #GDHEM #Oncology #Hematology #CancerCare

Is it time to move away from transplant in myeloma? Dr. Rafael Fonseca and Dr. Andrew Cowan will debate the role of ASCT in today’s evolving treatment landscape. www.gdhematology.com #GDHEM

Dr. Ami Neghandi shares why Great Debates in Solid Tumors stands out. From the smaller setting to the clinically focused debates, it offers something different. Hear her perspective and see why you should join us on Sept 13-14. Learn More: gdsolidtumors.com #GDST #MedicalEducation #Cancer #Oncology

BTK or BCL-2? The evidence continues to evolve, and with it, treatment decisions in CLL. In this session at #GDHEM, Dr. Catherine Coombs reviews the latest data on sequencing strategies, real-world AE management, and the role of MRD and molecular profiling in guiding care. www.gdhematology.com

GEJ cancer treatment planning isn’t always clear-cut. At #GDST, Drs. Biachi and Uboha debate neoadjuvant vs adjuvant strategies—downstaging, recurrence risk, and the role of ctDNA in refining decisions. Learn more: www.hmpglobalevents.com/gdst #GEJcancer #Oncology #CancerResearch

Are ICIs more impactful in locally advanced cervical cancer—or in the first-line metastatic setting with chemo? At #GDST, Drs. Leath and Duska will debate timing, trial data, & patient-specific impact. Join us in virtually or in Miami this September: gdsolidtumors.com #CervicalCancer #WomensHealth

CTLA-4 inhibitors aren’t standard in NSCLC but could that change? At #GDST, Drs. Rodriguez and Raez debate the potential role of CTLA-4 inhibition in lung cancer treatment today. Join us in Miami or virtually this September. Learn more: gdsolidtumors.com #LungCancer #NSCLC #Immunotherapy #Oncology

Still time to register for #GDHEM this month in NYC. Leaders in leukemia, lymphoma & myeloma will debate today’s most pressing treatment questions—so you leave with strategies that translate to clinic. 📍 June 28–29 | InterContinental Times Square 🔗 gdhematology.com #MedicalEducation #CancerCare

What’s next for low- and intermediate-risk MDS? Dr. Aditi Shastri joins us in New York City this month to talk symptom control, PROMs, and tailoring care for real patients—not just protocols. 🔗 gdhematology.com #MDS #Hematology #Oncology #CancerCare

Frontline treatment in advanced HCC continues to evolve. At #GDST, Drs. Harding and Alese will debate VEGF inhibition + ICI vs dual checkpoint blockade—exploring efficacy, sequencing, and patient selection. Join us for this pressing debate: www.hmpglobalevents.com/gdst #HCC #CancerCancer

First-line treatment in #DLBCL is evolving—fast. At #GDHEM, Dr. Sarah Rutherford reviews new frontline strategies, key trial data, and where care is headed for high-risk patients. Join us this month in New York City. Learn more at gdhematology.com #Lymphoma #Hematology #Oncology #ClinicalTrials

We’re heading to NYC this month for #GDHEM and proud to feature this outstanding group of faculty from across New York and New Jersey. Wondering how your peers are tackling the toughest questions in hematology? Join the conversation. 🔗 gdhematology.com #MedicalEducation #Oncology #Hematology

What if we treated by target, not tissue? At #GDST, Dr. David Hong explores the future of tumor-agnostic therapies—molecular drivers, AI, and what it means for precision oncology. Join us this September in Miami or virtually: www.hmpglobalevents.com/gdst #TargetedTherapy #Oncology #CancerCare

Frontline myeloma care is changing fast. At #GDHEM, Dr. @jmikhaelmd.bsky.social breaks down the shift to quadruplets, recent FDA approvals, and what’s next for transplant-eligible and ineligible patients. Join us in NYC: gdhematology.com #Myeloma #Hematology #Oncology ‪@cityofhope.bsky.social‬

Earlier use of novel endocrine therapies in HR+ breast cancer: do they make a difference here? Join Drs. Wander and Gandhi at #GDST as they debate the evidence, uncertainty, and impact of rethinking treatment lines. 📅 Sept 13–14 🔗 www.hmpglobalevents.com/gdst #BreastCancer #Oncology #bcsm

On #NationalCancerSurvivorsDay, we recognize the strength, persistence, and presence of cancer survivors everywhere. Your experiences continue to shape the future of care and support. #CancerSurvivorship #Oncology

📣 Meet the Florida-based experts shaping this year’s #GDST! Drs. Tiago Biachi, Gilberto Lopes, Nipun Merchant, Luis Raez, and ‪@latinamd.bsky.social‬ will join the debate-driven faculty lineup in Miami this September. Learn more: hubs.ly/Q03qLVx30 #MedicalEducation #CancerCare #Oncology

📣 Meet the Co-Chairs for #GDHEM! Drs. Jessica K. Altman, @johnpleonardmd.bsky.social‬, @jmikhaelmd.bsky.social are shaping a dynamic program that will tackle evolving standards and real-world decision-making in #hematology. Learn more: gdhematology.com #Oncology #Leukemia #Lymphoma #Myeloma

🩸 Every 27 seconds, someone in the world is diagnosed. On #WorldBloodCancerDay, we recognize how quickly a life can change. Blood donors are critical in the treatment of #leukemia, #lymphoma, #myeloma, and other #bloodcancers. If you're able, consider #BloodDonation and being part of that change.

🧬 Should all high-risk smoldering myeloma patients be treated? With new therapies available, is it time to move past “watch and wait”? Join Peter Voorhees, MD & Faith Davies, MD for this timely #GDHEM debate. 🗓️ NYC: June 28–29 | LA: July 26–27 🔗 gdhematology.com #Myeloma #Hematology #Oncology

Oncology nurses do more than care — they lead, advocate, and inspire. This #OncologyNursingMonth, we recognize their power to care beyond limits. #CaringBeyondLimits #OncologyNursing #CancerCare

Our Spring 2025 #DayofGiving is a week away! Register on May 21 for any Great Debates event & support the life-saving work of #LLS. We proudly support Janelle Bradley's campaign in memory of her father:  hubs.ly/Q03ml5SY0 Register on May 21: #GDHEM: hubs.ly/Q03mk_qd0 #GDST: hubs.ly/Q03ml5Qf0

🚨 Is Chemotherapy Still Necessary for Ph+ ALL? Join Elias Jabbour, MD and Shira Dinner, MD this summer as they debate "The Optimal Treatment Regimen for Ph+ ALL: Chemo-Free vs. Chemo + Allo-SCT." Where do you stand? Comment below! 🔗 gdhematology.com #GDHEM #Leukemia #BloodCancer

Today is #WorldOvarianCancerDay. We stand with those raising awareness, pushing for better care, and supporting all affected by ovarian cancer. #WOCD2025 #NoWomanLeftBehind #Oncology

The best insights don’t always come from the podium - they come from those in the room. Here’s what past attendees had to say about their experience at Great Debates in Solid Tumors. Join us in Miami: www.hmpglobalevents.com/gdst #GDST #MedicalEducation #GreatDebates #CancerCare

National Nurses Week 2025 kicks off today. This year’s theme is #ThePowerOfNurses — and it’s more than words. Thank you to every nurse making care possible, especially in oncology. #NationalNursesWeek #OncologyNursing

The Recommendation for HSCT in the Treatment of Acute Myeloid Leukemia Should be Determined Predominantly by MRD. Join Naval Daver, MD and Andrew Artz, MD for this critical debate shaping the future of AML treatment. 🔗 View the full agenda and register: gdhematology.com #GDHEM #AML #HSCT #Leukemia

May is #NationalCancerResearchMonth. It's a time to recognize the people and progress shaping cancer care. Thanks to research, 18 million in the U.S. are living beyond cancer. We’re grateful — and we’re not done yet. #CancerResearchMonth #Oncology #UnitedByResearch

🗣️ Is cfDNA the future of DLBCL management? Join @dgermain21.bsky.social, MD, PhD, and Sven de Vos, MD, PhD at #GDHEM as they debate the promise and challenges of cfDNA for diagnosis, monitoring, and treatment. 🔗 www.hmpglobalevents.com/gdhem #Hematology #Oncology #LiquidBiopsy #LymphomaResearch

Don’t just hear the data—discuss it. Join Dr. John Leonard and faculty for the Lymphoma Roundtable at #GDHEM, where research meets real-world care. 🗽 NYC: June 28–29 🌴 LA: July 26–27 🔗 www.hmpglobalevents.com/gdhem/rates #Hematology #Oncology #LymphomaCare

BTK inhibitors in mantle cell lymphoma: Upfront or second-line? This high-impact debate at #GDHEM brings clinical nuance, emerging data, and expert insight to the forefront. 🗓️ NYC: June 28–29 🗓️ LA: July 26–27 🔗gdhematology.com #Hematology #Oncology #MedicalEducation #LymphomaCare

Connect with experts and peers at #GDHEM in NYC or LA, and engage in thought-provoking discussions on: - Multiple myeloma sequencing strategies - CAR T-cell therapies in aggressive lymphomas - Advances in MDS, CLL, AML, and MPNs - And More! 🔗 gdHematology.com #Hematology #Oncology #BloodCancer

Esophageal cancer is rare — and often overlooked. It deserves louder conversations and more support. We stand with the patients, families, and care teams navigating it every day. 💜 #EsophagealCancerAwareness #GDST #MedicalEducation #Cancer

How are advancements shaping oncology and hematology? Join the Great Debates series to hear experts tackle clinical controversies, explore new treatments, and elevate patient care. #GreatDebates #Oncology #Hematology

Not your average GI oncology photo op at #GDST. Our co-chairs, Dr. Yelena Janjigian and Dr. @cathyengmd.bsky.social, not just leading the GI track—making the whole place shimmer! Leading important conversations and repping a little #Swiftie spirit. #MedicalEducation #CancerCare #GreatDebates

Back at it today! The rooms are filling up, the conversations are picking up, and we’re looking forward to what’s ahead. #GDST25 #MedicalEducation #Cancer

If you could make it (your argument) there, you’ll make it anywhere 🎵 Good night from Times Square New York at #GDST25 Getting ready to debate the utility of CTLA4i drugs in #lungcancer #GreatDebatesSolidTumors @SylvesterCancer

The rooms are full, the conversations are sharp, and the energy hasn’t dipped a bit. It’s been a great day of discussion so far at Great Debates in Solid Tumors—and we’re not done yet! #GDST25 #MedicalEducation #GreatDebates #Cancer

We are in full swing here at Great Debates in Solid Tumors with real-time discussions, practical insights, and a community that shows up ready to engage. Stay tuned for more moments from the day. #GDST25 #MedicalEducation #GreatDebates #Cancer

Always a pleasure to chair a meeting with Dr. Yelena Janjigian! Please join us for our 1st combined solid tumor hybrid meeting: Great Debates in Solid Tumors. @greatdebates.bsky.social Register: hmpglobalevents.com/gdst/agenda 🤩@NVijayvergiaMD #NET at 10AM today. #Cancer #cancerresearch

⏳ #GDST is just days away! Mix and match sessions across Lung, Gastrointestinal, and Women’s Cancers to fit your practice needs. Expert-led discussions cover: ⭐ Targeted Therapies ⭐ Checkpoint Inhibitors ⭐ ...and much more Don’t miss out—register now: gdsolidtumors.com #MedicalEducation #Cancer

One week until Great Debates in Solid Tumors! Join @drkatymoore.bsky.social as she discusses advances in Antibody Drug Conjugates for gynecologic cancer. Essential insights for your practice. Register: gdsolidtumors.com Code: MARCHLAST #GDST25 #MedicalEducation #Cancer

There’s still time to join Great Debates in Solid Tumors on March 22–23 in NYC! Why Attend? Choose from sessions across Women’s, Lung, and Gastrointestinal cancers, led by top oncology experts. Register now → gdsolidtumors.com Use Code: MARCHLAST #GDST25 #MedicalEducation #Cancer #GreatDebates

💙 swag in my mailbox to help encourage people to get screened!! 🔵 R U >/= 45 yo? 🔵Have U had a change in bowel habits? 🔵Do U have a family hx of #ColorectalCancer or uterine #cancer ? 🔵 Any unresolved symptoms? 👉🏻 Talk to your MD #ColorectalCancerAwarenessMonth @vumc-insights.bsky.social

Dr. Seth Wander (MGH) leads a roundtable on PI3K pathway mutations & their impact on treatment. Joined by Drs. Kelly McCann (UCLA), Megan Kruse & Janice Lu to discuss PIK3CA testing & emerging therapies. 🔗 bit.ly/3QOPlrD Catch Drs. Wander & McCann at #GDST: gdsolidtumors.com #BreastCancer

Colorectal Cancer Awareness Month calls attention to the life-saving power of screenings and preventive measures. #GDST supports the oncology community by sharing practical insights that can help clinicians improve outcomes for their patients. #ColorectalCancer #CancerAwareness #ScreeningSavesLives

Leading experts from @mskcancercenter.bsky.social are speaking at Great Debates in Solid Tumors! Hear from Drs. Yelena Janjigian (Co-chair), Jamie Chaft, Samuel Cytryn, James Harding, Ying Liu, Helena Yu, Nour Abuhadra, and Gregory Riely. Register today: gdsolidtumors.com #GDST #MedicalEducation